511 related articles for article (PubMed ID: 32478631)
1. Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments.
Greenway KT; Garel N; Jerome L; Feduccia AA
Expert Rev Clin Pharmacol; 2020 Jun; 13(6):655-670. PubMed ID: 32478631
[TBL] [Abstract][Full Text] [Related]
2. Compassionate use of psychedelics.
Greif A; Šurkala M
Med Health Care Philos; 2020 Sep; 23(3):485-496. PubMed ID: 32468195
[TBL] [Abstract][Full Text] [Related]
3. Psychedelics and Psychedelic-Assisted Psychotherapy.
Reiff CM; Richman EE; Nemeroff CB; Carpenter LL; Widge AS; Rodriguez CI; Kalin NH; McDonald WM;
Am J Psychiatry; 2020 May; 177(5):391-410. PubMed ID: 32098487
[TBL] [Abstract][Full Text] [Related]
4. Psychedelic-Assisted Group Therapy: A Systematic Review.
Trope A; Anderson BT; Hooker AR; Glick G; Stauffer C; Woolley JD
J Psychoactive Drugs; 2019; 51(2):174-188. PubMed ID: 30950777
[TBL] [Abstract][Full Text] [Related]
5. Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?
Majić T; Schmidt TT; Gallinat J
J Psychopharmacol; 2015 Mar; 29(3):241-53. PubMed ID: 25670401
[TBL] [Abstract][Full Text] [Related]
6. Review of potential psychedelic treatments for PTSD.
Henner RL; Keshavan MS; Hill KP
J Neurol Sci; 2022 Aug; 439():120302. PubMed ID: 35700643
[TBL] [Abstract][Full Text] [Related]
7. The Emerging Field of Psychedelic Psychotherapy.
Barber GS; Aaronson ST
Curr Psychiatry Rep; 2022 Oct; 24(10):583-590. PubMed ID: 36129571
[TBL] [Abstract][Full Text] [Related]
8. Psychedelic Psychiatry: Preparing for Novel Treatments Involving Altered States of Consciousness.
Holoyda B
Psychiatr Serv; 2020 Dec; 71(12):1297-1299. PubMed ID: 33050796
[TBL] [Abstract][Full Text] [Related]
9. Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine with Psychotherapy.
Dore J; Turnipseed B; Dwyer S; Turnipseed A; Andries J; Ascani G; Monnette C; Huidekoper A; Strauss N; Wolfson P
J Psychoactive Drugs; 2019; 51(2):189-198. PubMed ID: 30917760
[TBL] [Abstract][Full Text] [Related]
10. Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions.
Garcia-Romeu A; Richards WA
Int Rev Psychiatry; 2018 Aug; 30(4):291-316. PubMed ID: 30422079
[TBL] [Abstract][Full Text] [Related]
11. Psychedelic drugs for psychiatric disorders.
da Costa SC; Oesterle T; Rummans TA; Richelson E; Gold M
J Neurol Sci; 2022 Sep; 440():120332. PubMed ID: 35841696
[TBL] [Abstract][Full Text] [Related]
12. Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.
Perkins D; Sarris J; Rossell S; Bonomo Y; Forbes D; Davey C; Hoyer D; Loo C; Murray G; Hood S; Schubert V; Galvão-Coelho NL; O'Donnell M; Carter O; Liknaitzky P; Williams M; Siskind D; Penington D; Berk M; Castle D
Aust N Z J Psychiatry; 2021 Dec; 55(12):1127-1133. PubMed ID: 33745287
[TBL] [Abstract][Full Text] [Related]
13. Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer.
Barnett BS; Greer GR
J Acad Consult Liaison Psychiatry; 2021; 62(4):460-471. PubMed ID: 34210406
[TBL] [Abstract][Full Text] [Related]
14. Older adults in psychedelic-assisted therapy trials: A systematic review.
Bouchet L; Sager Z; Yrondi A; Nigam KB; Anderson BT; Ross S; Petridis PD; Beaussant Y
J Psychopharmacol; 2024 Jan; 38(1):33-48. PubMed ID: 38240068
[TBL] [Abstract][Full Text] [Related]
15. Awe: a putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy.
Hendricks PS
Int Rev Psychiatry; 2018 Aug; 30(4):331-342. PubMed ID: 30260256
[TBL] [Abstract][Full Text] [Related]
16. Psychedelics and hypnosis: Commonalities and therapeutic implications.
Lemercier CE; Terhune DB
J Psychopharmacol; 2018 Jul; 32(7):732-740. PubMed ID: 29938563
[TBL] [Abstract][Full Text] [Related]
17. [Neurotrophic mechanisms of psychedelic therapy].
Corne R; Mongeau R
Biol Aujourdhui; 2019; 213(3-4):121-129. PubMed ID: 31829932
[TBL] [Abstract][Full Text] [Related]
18. Why MDMA therapy for alcohol use disorder? And why now?
Sessa B
Neuropharmacology; 2018 Nov; 142():83-88. PubMed ID: 29126911
[TBL] [Abstract][Full Text] [Related]
19. Psychedelics and Psychotherapy.
Nayak S; Johnson MW
Pharmacopsychiatry; 2021 Jul; 54(4):167-175. PubMed ID: 33285578
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
